imatinib has been researched along with Experimental Neoplasms in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " A pharmacokinetic study revealed that 18a had over 4 h of half-life and 24% bioavailability in rats." | 1.43 | Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Le ( Chen, C; Hu, Z; Liang, X; Liu, J; Liu, Q; Liu, X; Lv, F; Qi, S; Qi, Z; Wang, A; Wang, B; Wang, L; Wang, W; Zhang, S; Zhao, Z; Zou, F, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, X | 1 |
| Liu, X | 4 |
| Wang, B | 3 |
| Zou, F | 1 |
| Wang, A | 3 |
| Qi, S | 2 |
| Chen, C | 3 |
| Zhao, Z | 1 |
| Wang, W | 6 |
| Qi, Z | 2 |
| Lv, F | 1 |
| Hu, Z | 3 |
| Wang, L | 3 |
| Zhang, S | 2 |
| Liu, Q | 4 |
| Liu, J | 3 |
| Wang, Q | 1 |
| Liu, F | 1 |
| Yan, XE | 1 |
| Jiang, Z | 2 |
| Ren, T | 2 |
| Yun, CH | 1 |
| Hu, C | 1 |
| Wu, H | 1 |
| Zhang, Y | 1 |
| Wang, J | 1 |
| Huang, T | 1 |
| Li, L | 1 |
| Xia, R | 1 |
| Ge, J | 1 |
3 other studies available for imatinib and Experimental Neoplasms